Cargando…
Efficacy of amisulpride and olanzapine for negative symptoms and cognitive impairments: An open-label clinical study
BACKGROUND: Negative symptoms and diminished cognitive ability are also considered as core features of schizophrenia. There are many studies in which negative symptoms and cognitive impairments are individually treated with atypical antipsychotic in comparison with either a placebo or a typical anti...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261210/ https://www.ncbi.nlm.nih.gov/pubmed/25535442 http://dx.doi.org/10.4103/0972-6748.144953 |